Prosus’s red report card for underperformers Byju’s, PharmEasy
This is the third time Prosus has marked down its valuation of the beleaguered edtech firm within a year.
30 November, 2023•1 min
0
30 November, 2023•1 min
0
More in
Business
Yes Bank’s succession problem is a board problem
As Prashant Kumar’s term runs out, boardroom fault lines have left the lender with no clarity on its next CEO—spooking investors and drawing the RBI’s ire.
You may also like
Business
Yes Bank’s succession problem is a board problem
As Prashant Kumar’s term runs out, boardroom fault lines have left the lender with no clarity on its next CEO—spooking investors and drawing the RBI’s ire.
Business
JSW Energy’s acquisition engine is working—and that is a worry
Rapid asset purchases are driving generation growth, but rising debt and weaker cash flows are testing investor confidence.
Business
UAE conglomerates set their sights on India
A series of new investments earmarked for India, good and bad news from Saudi Arabia and AI deals at Davos, among other updates.